Optimi Health Corp. (OPTH)
NASDAQ: OPTH · Real-Time Price · USD
5.64
-0.33 (-5.53%)
At close: Jun 1, 2026, 4:00 PM EDT
5.74
+0.10 (1.77%)
After-hours: Jun 1, 2026, 5:59 PM EDT
Optimi Health Revenue
Optimi Health had revenue of 193.60K CAD in the twelve months ending December 31, 2025, down -62.59% year-over-year. In the fiscal year ending September 30, 2025, Optimi Health had annual revenue of 426.30K with 9.35% growth.
Revenue (ttm)
193.60K CAD
Revenue Growth
-62.59%
P/S Ratio
227.59
Revenue / Employee
24,200 CAD
Employees
8
Market Cap
32.14M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Sep 30, 2025 | 426.30K | 36.45K | 9.35% |
| Sep 30, 2024 | 389.85K | 208.76K | 115.28% |
| Sep 30, 2023 | 181.09K | 100.37K | 124.35% |
| Sep 30, 2022 | 80.72K | - | - |
| Sep 30, 2021 | - | - | - |
| Sep 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Rockwell Medical | 67.68M |
| Aytu BioPharma | 56.60M |
| BGM Group | 25.10M |
| SCYNEXIS | 20.34M |
| Zhengye Biotechnology Holding | 16.64M |
| China Pharma Holdings | 3.99M |
| TherapeuticsMD | 3.35M |
| BioXcel Therapeutics | 680.00K |
OPTH News
- 3 days ago - Optimi Health reports expanded psychedelic-assisted therapy access in Australia - TheFly
- 3 days ago - Optimi Health Welcomes Expanded Psychedelic-Assisted Therapy Access Under Updated Authorized Prescriber Framework in Australia - GlobeNewsWire
- 4 days ago - Psychedelic: Optimi Health advances natural psilocybin extract - TheFly
- 5 days ago - Diamond Equity Research Initiates Coverage on Optimi Health Corp. (NASDAQ: OPTH) (CSE: OPTI) (FSE: 8BN) - GlobeNewsWire
- 6 days ago - Optimi Health Advances Highest-Purity Natural Psilocybin Extract to Date - Newsfile Corp
- 11 days ago - Optimi Health Announces Closing of Oversubscribed US$15 Million Public Offering - Newsfile Corp
- 11 days ago - SRx Health Solutions and EMJX Invest in Recent IPO and Commercial-Stage Pharmaceutical Company of Psychedelics, Optimi Health Corp. (OPTH) - GlobeNewsWire
- 12 days ago - Optimi Health Announces Pricing of Oversubscribed US$15 Million Public Offering and Nasdaq Uplisting - Newsfile Corp